Sign in
Poster: ABCL-022: LOTIS-2 Follow-Up Analysis: Updated Results from a Phase 2 Study of Loncastuximab Tesirine (Lonca) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Journal article   Peer reviewed

Poster: ABCL-022: LOTIS-2 Follow-Up Analysis: Updated Results from a Phase 2 Study of Loncastuximab Tesirine (Lonca) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Brad S Kahl, Mehdi Hamadani, Paolo F Caimi, Carmelo Carlo-Stella, Weiyun Ai, Juan Pablo Alderuccio, Kirit M Ardeshna, Brian Hess, John Radford, Melhem Solh, …
Clinical lymphoma, myeloma and leukemia, Vol.21, pp.S238-S238
2021-09

Metrics

5 Record Views

Details